PERSELIS

Trademark usage description

pharmaceutical preparations for the treatment of mental health diseases and disorders, for the treatment of the central nervous system, namely, brain Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of mental health diseases and disorders, for the treatment of the central nervous system, namely, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, schizophrenia, and central nervous system perception disorders, central nervous system feeling disorders, and central nervous system behavioral disorders; medicines for human and veterinary purposes, namely, medicines for the treatment of mental health diseases and disorders, for the treatment of the central nervous system, namely, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, schizophrenia, and central nervous system perception disorders, central nervous system feeling disorders, and central nervous system behavioral disorders

Classification kind code

Mark Details

Serial Number

1988531

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 6 on 13^th Feb 2025	Abandoned - Section 36
Submitted for opposition 14 on 26^th Nov 2024	Default Notice Sent
Submitted for opposition 22 on 8^th May 2024	Search Recorded
Submitted for opposition 20 on 8^th May 2024	Examiner's First Report
Submitted for opposition 67 on 7^th Oct 2022	Agent Name Changed
Submitted for opposition 287 on 3^rd Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 31 on 17^th Oct 2019	Formalized
Submitted for opposition 30 on 4^th Oct 2019	Filed
Submitted for opposition 1 on 4^th Oct 2019	Created